Heggem IM, Soto GW, Guthe HJ, Hikmat O. The impact of imposter phenomenon: an unmet need in the education of healthcare personnel- a cross-sectional study. BMC Med Educ. 2025 Nov 21;25(1):1745. doi: 10.1186/s12909-025-08349-3. PMID: 41272718; PMCID: PMC12752308.
Razaz N, Soderling J, Tomson T, et al
Risk of neurodevelopmental disorders associated with paternal use of valproate during spermatogenesis
Journal of Neurology, Neurosurgery & Psychiatry Published Online First: 04 March 2026. doi: 10.1136/jnnp-2025-337441
Kristensen E, Naess K, Engvall M, Klingenberg C, Rasmussen M, Brodtkorb E, Ostergaard E, de Coo I, Pias-Peleteiro L, Isohanni P, Uusimaa J, Majamaa K, Kärppä M, Martikainen MH, Ortigoza-Escobar JD, Tangeraas T, Berland S, Sue CM, Walker JS, Harrison E, Biggs H, Horvath R, Darin N, Rahman S, Hikmat O. Liver Involvement in POLG Disease-a Multicentre Cohort Study of 202 Patients. J Inherit Metab Dis. 2025 Nov;48(6):e70112. doi: 10.1002/jimd.70112. PMID: 41239934.
Neugebauer J, Reinson K, Bellusci M, Park JH, Hikmat O, Bertini E, Schiff M; MetabERN PM‐MD Consortium authors; Rahman S. Current global vitamin and cofactor prescribing practices for primary mitochondrial diseases: Results of a European reference network survey. J Inherit Metab Dis. 2025 Jan;48(1):e12805. doi: 10.1002/jimd.12805. Epub 2024 Nov 11. PMID: 39529390; PMCID: PMC11670042.
Møen EN. & Mahesparan R. Frailty in Geriatric Neurosurgery: Real-World Data from 328 Octogenarian Patients (2025). [In press].
Møen EN., Schipmann S., Hartmark Nilsen M., Øksnes M., Lund-Johansen M. & Mahesparan R. (2025). Disease-Specific Quality Indicators for Surgical Treatment of Pituitary Adenomas: Results from a Single-Center Retrospective Case-Series. [In press].
Møen, EN., Bjørk, M-H., Gilhus, NE., Daltveit, D. S., Contreras, D., Hagen, K., Jayaraman, M., Khanevski, A. N., Wergeland, T., Stubberud, A., Tronvik, E. A., & Igland, J. (2025). The Prevalence and Incidence of Cluster Headache: A Norwegian Registry-Based Time-Trend Study. [In press].
Møen EN, Dalgeir A-MT, Linde M, Wergeland T, Tronvik E, Igland J, et al. The effect of whole-body resistance exercise versus non-exercise on primary headaches: A scoping review and exploratory meta-analysis. Cephalalgia Reports. 2025;8:25158163251383149.
Gilhus NE, Maniaol AH. Myasthenia gravis; ny og bedre behandling. Tidsskr Nor Legeforen 2025;145:1268-1273.. Vincent A, Berrih-Aknin S, Brenner T, Chalk C, Corbin D, Cortez-Vicente E, Deymeer
F, Evoli A, Eymard B, Gilhus NE, Heckman J, Hoch W, Iles Z, Kleopa K, Kostera- Pruszczyk A, Kuwabara S, Lee K-W, Lisak R, Mantegazza R, Melms A, Motomura M, Nafissi S, Nicolle M, Oger J, Reddel S, Roda R, Rosales R, Saliuto V, Sanders D, Spinazzi M, Verschuuren J, Vissing J, Witoonpanich R. International study on the relative prevalence of MuSK antobody myasthenia gravis. 2026; submitted.
Hong Y, Li H-F, Guo Y, Liu L, Skeie GO, Wang J, Gilhus NE. CpG island hypomethylation drives the expression of molecules homologous to the muscle autoantigens acetylcholine receptor and ryanodine receptor in thymoma epithelial cells associated with myasthenia gravis. 2025; manuscript.
Rotstein DL, Alroughani R, Arrambide G, Contentti EC, Chomba M, Fujihara K, Gilhus NE, Gouider R, Heckmann JM, Kim HJ, Li H-F, Leite MI, Monif M, Siritho S, Thiel S, Vishnevetsky A, Viswanathan S, Vukusic S, Yamout B, Klimpfel T, Hellwig K. Family planning and pregnancy in the antibody-mediated neuroimmune disorders myasthenia gravis, NMOSD, and MOGAD: current evidence and knowledge gaps. Lancet Neurol 2025; in press.
Cai Q, Gandhi K, Imran N, Batyrbekova N, Isheden G, Ait-Tibyaty M, Kwong WJ, Hewamadduma C, Gilhus NE. Impact of long-term oral corticosteroids usage on overall survival among pateints with myasthenia gravis; a nationwide population-based study. 2025; submitted.
Jacob S, Hashim M, Hutton B, Gandhi K, Sanden SV, Slowik R, Drudge C, Khoury ACE, Keng MJ, Singh S, Ramehanderen, S, Gilhus NE. Indirect comparison of nipocalimab versus efgartgimod and rozanolixizumab in the treatment of generalized myaasthenia gravis. 2025; submitted.
Gilhus NE. Myasthenia gravis with acetylcholine receptor antibodies in the very old; treatment challenges and diagnostic pitfalls. 2026; submitted.
Sacconi S, Vanoli F, Stascheit F, Cortes-Vicente E, Mantegazza R, Meisel A, Santos E, Verschuuren J, Gilhus NE, Laforet P, Hoen PB, Marian AD, Antozzi C, Campana ES, Maggi L, Ashragi M, Vohanka S, Brauner S, Evangelista T, Spandonaro F, Hoffmeister
A, Gary C, Hudson C, Calawaert F, Tibung JT, Allard L, Lusignan M, Pardo R. European Standards for harmonization of myasthenia gravis registries and emerging digital solutions. Neuromusc Disord 2025;105368:1-11.
Narayanaswami P, Mantegazza R, Barnett-Tapia C, Cortes-Vicente E, Freimer M, Gilhus NE, Habib AA, Howard JF, Kostera-Pruszczyk A, Leite MI, Meisel A, Pasnoor M, Sacconi S, Silvestri NJ, Suzuki S, Urawa A, Wolfe GI, Utsugisawa K. Treatment goals in myasthenia gravis; expert consensus recommendations using a RAND/UCLA appropriateness method. 2025;submitted.
Lundøy RE, Sigvathsen A, Lindroos JLV, Gilhus NE, Bjørk MH. Risk of neurodevelopmental disorders after topiramate exposure; a systematic review. 2025; submitted.
Rektorova I, Ahmad H, Babakhani AA, Benson M, Carneiro D, Fronczek R, Gilhus NE, Jelmoni A, Kent JA, Moro E, Nasr N, Padovani A, Martins IP, Tabuas-Pereira M, Vodusek DB, Soffietti R. Undergraduate curriculum in neurology; recommendation and guidance paper. 2025; manuscript.
Gilhus NE. Myasthenia gravis complicated with autoimmune encephalitis; a systematic review. 2025; submitted.
Evoli A, Gilhus NE, Sanders D. Immunotherapies in autoimmune neuromuscular junction disorders; acute and chronic management. Handb in ClinNeurol 2026;214:395-415.
Stovner LJ, Gilhus NE, Fyhn M, Buschmann E, Peersen H. Prevalence and burden of brain disorders in Norway. 2025, manuscript.
Slioui A, Tammam G, Vanoli F, Marina AD, Vohanka S, Gilhus NE, Moroni I, Leite MI, Piehl F, Antozzi C, Pini J, Stascheit F, Attarian S, Santos E, Verschuuren J, Canonge L, Garcia J, Perriard C, Cortes-Vicente E, Mantegazza R, Meisel A, Sacconi S. Toward European harmonization of national myasthenia gravis registries: Modified Delphi procedure-based expert consensus on collectable data. Orph J Rare Diseases 2025;20:115.
Sobierajski T, Krzystanek M, Fojcik J, Lasek-Bal A, Gilhus NE. Impact of myasthenia gravis on patients’ lives from a biopsychosocial perspective. 2025; manuscript.
Sun Y, Alvestad S, Cohen JM, Igland J, Gilhus NE, Vegrim HM, Furu K, Tomson T, Christensen J, Leinonen MK, Gissler M, Zoega H, Razaz N, Dreier JW, Bjørk MH. High-dose folic acid in women taking antiseizure medication and risk for congenital anomalies. J Neurol Neurosurg Psychiat 2026; in press.
Writing Committee for the PERSIST Collaborators; Khan F, Yogendrakumar V, Lun R, Ganesh A, Barber PA, Lioutas VA, Vinding NE, Algra A, Weimar C, Ögren J, Edwards JD, Swartz RH, Ois A, Giralt-Steinhauer E, Khanevski AN, Leng X, Tian X, Leung TW, Park HK, Bae HJ, Kamouchi M, Ago T, Verburgt E, Verhoeven J, de Leeuw FE, Berghout BP, Ikram MK, Kostev K, Whiteley W, Uehara T, Minematsu K, Ildstad F, Fandler-Höfler S, Aarnio K, von Sarnowski B, Foschi M, Jing J, Baik M, Kim YD, Spampinato MD, Hasegawa Y, Perera K, Purroy F, Dutta D, Yang X, Lippert J, Myers L, Bravata DM, Santos M, Coveney S, Garcia-Esperon C, Levi CR, Lorenzetti DL, Vatanpour S, Wang Y, Albers GW, Lavallee P, Amarenco P, Coutts SB, Hill MD. Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis. JAMA. 2025 May 6;333(17):1508-1519. doi: 10.1001/jama.2025.2033.
Ryan SJ, Jørstad ØK, Skjelland M, Simonsen CZ, Bek T, Blauenfeldt RA, Ijäs P, Laitinen A, Khanevski AN, Krohn J, Rødahl E, Lemmens R, Demeestere J, Cassiman C, Nakstad I, Evensen K, Sandell T, Hamann S, Christensen LM, Rosenbaum S, Matijosaitis V, Zemaitiene R, Ellekjær H, Austeng D, Truelsen TC, Mazya MV, Träisk F, Ylikotila P, Salmi U, Jenssen KN, Lisether H, Breivik C, Devik K, Honningsvåg LS, Valaikienė J, Cimbalas A, Malmberg VN, Anderson E, De Raedt S, Tusscher MT, Ligot N, Lipski D, Björck F, Hamrin A, Solbakken T, Tharaldsen AR, Farmen AH, Helgesen A, Johnsen SH, Bertelsen G, Morsund ÅH, Holen E, Tveiten A, Johannessen HB, Kelly P, O'Neill E, Roy A, Kefaloykos C, Skattør TH, Kraglund KL, Sanders L, Vanacker P, Strbian D, Moe MC, Aamodt AH. Tenecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): Protocol for a randomized-controlled trial. Eur Stroke J. 2025 Dec;10(4):1502-1510. doi: 10.1177/23969873251344199.
Lindroos JLV, Bjørk M-H, Cohen JM, et al. Obstetric and Neonatal Outcomes in Patients With Maternal Myasthenia Gravis. Neurology. 2025;105(8):e214139. doi:doi:10.1212/WNL.0000000000214139
Øie LR, Wergeland T, Salvesen Ø, et al. Candesartan versus placebo for migraine prevention in patients with episodic migraine: a randomised, triple-blind, placebo-controlled, phase 2 trial. The Lancet Neurology. 2025;24(10):817-827. doi:10.1016/s1474-4422(25)00269-8
Sandrine Colas, Juliette Longin, Ana Cristina Santos, Sigal Kaplan, Romina di Giuseppe, David Bigat, Alessandra Venerus, Marte-Helene Bjørk, Marie-Laure Kürzinger, Maria Roberta Cilio, Florent Richy Valproate Use and Neurodevelopmental Disorder and Congenital Malformation Risk in Offspring. JAMA Netw Open. 2025 Nov 3;8(11):e2542581
Fahim Faisal, Antonios Danelakis, Marte-Helene Bjørk, Bendik Winsvold , Manjit Matharu , Parashkev Nachev , Knut Hagen, Erling Tronvik, Anker Stubberud Prediction of new-onset migraine using clinical-genotypic data from the HUNT Study: a machine learning analysis. J Headache Pain. 2025;26(1):70.
Lise R. Øie, Tore W. Meisingset, Øyvind Salvesen, Gøril B. Gravdahl, Sasha Gulati, Marte-Helene Bjørk.. Lars J. Stovner, Erling Tronvik Candesartan for the Preventive Treatment of Episodic Migraine The Lancet Neurology, Volume 24, Issue 10, 2025,
Akash Kapali, Anne Kjersti Daltveit, Kjell-Morten Myhr, Kjetil Bjornevik, Karine Eid, Marte-Helene Bjørk, Anne Lise Brantsæter, Trond Riise, Marianna Cortese, Vitamin D intake and multiple sclerosis risk in the Norwegian Mother, Father and Child cohort. JNNP 2025 Nov 28:jnnp-2025-337300. doi: 10.1136/jnnp-2025-337300.
Emilie Willoch Olstad , Hedvig Marie Egeland Nordeng , Marte-Helene Bjørk, Kaja Selmer, Kristina Gervin Paternal valproate use and impact of shared genetic susceptibility on child neurodevelopment. Sci Rep. 2025 Nov 7;15(1):39033.
Kristine Blix, Ida Laake, Ida Henriette Caspersen, Berit Feiring, Anna Hayman Robertson, Siri N. Skodvin, Siri Mjaaland, Per Magnus, Erling Andreas Tronvik, Anker Stubberud, Marte-Helene Bjørk, Lill Trogstad New-onset headache after SARS-CoV-2 infection and vaccination; results from three population-based cohorts in Norway Eur J Neurol. 2025 Dec;32(12):e70437.
Yi Li Rebecca Bromley, Kimford J. Meador, Marte-Helene Bjørk, Page B. Pennell MD, P. Emanuela Voinescu, For the Epilepsy in the Childbearing Age through Menopause Consortium (ECAM) Folate Supplement Dosage for Pregnant People with Epilepsy: Survey of International Experts Recommendation and Current Practices. Epileptic Disord. 2025. doi:10.1002/epd2.70097
Poole AC, Stubberud A, Simpson M, Øie L, Skalstad ETV, Bjørk MH, Kristoffersen ES, Vetvik KG, Olsen A, Larsen ICK, Linde M, Tronvik EA, Meisingset TW. Biofeedback therapy using Cerebri for the prevention of migraine attacks in adults with episodic migraine (BioCer): a randomized, wait-list controlled trial - the study protocol. F1000Res. 2025 Aug 29;13:775.
Amalie Christine Poole, Ingunn Grøntveit Winnberg, Melanie Rae Simpson, Anker Stubberud, Kjersti Grøtta Vetvik, Marte-Helene Bjørk, Lise Rystad Øie, Petter Holmboe, Alexander Olsen, Erling Tronvik, Tore Wergeland. Feasibility of a 12-Week, Therapist-Independent, Smartphone-Based Biofeedback Treatment for Episodic Migraine in Adults: Single-Center, Open-Label, 1-Armed Trial. JMIR Hum Factors. 2025;12:e59622. Published 2025 Jun 9. doi:10.2196/59622
Møen, E.N., Schipmann, S. & Mahesparan, R. Meeting tomorrow’s needs: a single-centre study in geriatric neurosurgery. BMC Geriatr 25, 821 (2025). doi.org/10.1186/s12877-025-06489-1
doi.org/10.1186/s12877-025-06489-1Møen EN, Dalgeir A-MT, Linde M, et al. The effect of whole-body resistance exercise versus non-exercise on primary headaches: A scoping review and exploratory meta-analysis. Cephalalgia Reports. 2025;8. doi:10.1177/25158163251383149
Bjørk, M. H., Cukiert, C., Nucera, B., & Bromley, R. L. (2025). Management of reproductive risks in people with epilepsy. The Lancet Neurology, 24(7), 601–613. https://doi.org/10.1016/S1474-4422(25)00130-9
Danelakis, A., Winsvold, B. S., Bjørk, M. H., Giles, D., Nachev, P., Kumelj, T., Hagen, K., Matharu, M., Nyholt, D. R., Tronvik, E., Langseth, H., & Stubberud, A. (2025). Diagnosing migraine from genome-wide genotype data: A machine learning analysis. Brain. Advance online publication. https://doi.org/10.1093/brain/awaf172
Lindroos, J. L. V., Bjørk, M.-H., Cohen, J. M., Danielsson, K. C., Hikmat, O., Midelfart Hoff, J., & Gilhus, N. E. (2025). Obstetric and neonatal outcomes in patients with maternal myasthenia gravis: A nationwide cohort study. Neurology. In press.
Bugge, C., Engebretsen, I., Kristiansen, I. S., Sæther, E. M., Schager, I. S., Arneberg, F., & Gilhus, N. E. (2025). Real-world evidence to estimate medical costs among patients with myasthenia gravis treated with intravenous immunoglobulin (IVIG). Journal of Neurology, 272, 15. https://doi.org/10.1007/s00415-025-12838-3
Razaz, Y., Bromley, R., Meador, K. J., Bjørk, M.-H., Pennell, P. B., & Voinescu, P. E. (2025). Folate supplement dosage for pregnant people with epilepsy: Survey of international experts. Epileptic Disorders. In press.
Bril, V., & Gilhus, N. E. (2025). Aging and infectious diseases in myasthenia gravis. Journal of the Neurological Sciences, 468, 123314. https://doi.org/10.1016/j.jns.2025.123314
Andersen, H., Andersen, N. B., Asztely, F., Ben-Menachem, E., Gauffin, H., Gerstner, T., Gordon, L., Hikmat, O., Ingebrigtsen, S., Kolbjer, S., Kostov, H., Lamusuo, S., Lillebø, A., Lundgren, J., Marjanovic, D., Metsähonkala, L., Olofsson, K., Roivainen, R., Sabers, A., … Peltola, J. (2025). Programming in vagus nerve stimulation therapy: Consensus from a Nordic Delphi Panel. Seizure, 131, 423–434. https://doi.org/10.1016/j.seizure.2025.08.014
Eid, K., Bjørk, M. H., & Gilhus, N. E. (2025). Adverse childhood experiences and the risk of multiple sclerosis development: A review of potential mechanisms. International Journal of Molecular Sciences, 25(3), 1520. https://doi.org/10.3390/ijms25031520
Evoli, A., Palace, J., Verschuuren, J., Maggi, L., Niks, E., Ramdas, S., Natera, D., Schara, U., Cortes-Vicente, E., Behin, A., Hoffmann, S., Gilhus, N. E., Vissing, J., Heckman, J., Sanders, D., Punga, A. R., Tannemaat, M., Mantegazza, R., Schreiner, B., … Damato, V. (2025). Seronegative myasthenia gravis: An updated paradigm for diagnosis and management. Neuromuscular Disorders. Advance online publication.
Faisal, M., Danelakis, A., Bjørk, M. H., Winsvold, B. S., Nachev, P., Matharu, M., International Headache Genetics Consortium, Hagen, K., Langseth, H., Tronvik, E., & Stubberud, A. (2025). Prediction of new-onset migraine using clinical-genotypic data from the HUNT Study: A machine learning analysis. The Journal of Headache and Pain, 26(1), 70. https://doi.org/10.1186/s10194-025-01837-2
Gilhus, N. E. (2025). Myasteni. Norsk legemiddelhåndbok. In press.
Gilhus, N. E. (2025). Postpolio-syndrom må få mer oppmerksomhet. Tidsskrift for Den norske legeforening, 145, 53. https://doi.org/10.4045/tidsskr.25.0053
Gilhus, N. E., & Breiner, A. (2025). Epidemiology of myasthenia gravis. International Review of Neurobiology, 182, 161–196. https://doi.org/10.1016/bs.irn.2025.03.009
Gilhus, N. E., Jacob, S., Hashim, M., Sanden, S. V., Drudge, C., Nero, A., Singh, S., Gandhi, K., & Hutton, B. (2025). Network connectivity between-study heterogeneity and timepoint challenges in generalized myasthenia gravis: A feasibility assessment of indirect treatment comparisons. Journal of Comparative Effectiveness Research, 14(6), 0009. https://doi.org/10.2217/cer-2025-0009
Møen, E. N., Helland, C. A., & Mahesparan, R. (2025). Complications and risk factors of endoscopic third ventriculostomy: A 10-year single-centre study and systematic literature review. Brain & Spine, 5, 104291. https://doi.org/10.1016/j.bas.2025.104291
Olstad, E. W., Nordeng, H., Bjørk, M. H., Selmer, K. K., & Gervin, K. (2025). Use and dispensed prescription records from a national prescription database. Pharmacoepidemiology and Drug Safety, 34(4), e70139. https://doi.org/10.1002/pds.70139
Razaz, N., Igland, J., Bjørk, M.-H., Joseph, K. S., Dreier, J. W., Gilhus, N. E., Gissler, M., Leinonen, M. K., Zoega, H., Alvestad, S., Christensen, J., & Tomson, T. (2025). Risk of perinatal and maternal morbidity and mortality among pregnant women with epilepsy. JAMA Neurology, 81(9), 985–995. (Published online 2024, print 2025). https://doi.org/10.1001/jamaneurol.2024.2137
Tronrud, T., Hirnstein, M., Eichele, T., Kolstad, E., & Marquardt, L. (2025). Transcranial direct current stimulation treatment reduces, while repetitive transcranial magnetic stimulation treatment increases electroencephalography spike rates with refractory occipital lobe epilepsy: A case study. Epilepsia Open, 10(3), 749–757. https://doi.org/10.1002/epi4.70024
Varhaug, K. N., Anaestad, E., Holmaas, G., Wollertsen, Y. M., Berland, S., Veiby, G., Eichele, T., Bjørk, M.-H., Rahman, S., & Hikmat, O. (2025). The impact of induced burst-suppression on outcomes in patients with POLG-related status epilepticus. Seizure. In press.
Vegrim, H. M., Dreier, J. W., Igland, J., Alvestad, S., Gilhus, N. E., Gissler, M., Leinonen, M. K., Tomson, T., Zoega, H., Christensen, J., & Bjørk, M. H. (2025). High-dose folic acid supplementation and risk of cancer in persons who have given birth: A register-based cohort study. Epilepsia, 66(1), 75–88. https://doi.org/10.1111/epi.17800